Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathleen Kearney, MD
University of Washington
Principal Investigator - Sherry Lane
Teleflex
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heart Health Institute
Scarborough Village, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Sunnybrook Heath Sciences Center
Toronto, Ontario, Canada
- Torrance Memorial Medical Center
Torrance, California, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- St. Luke'S Hospital
Kansas City, Missouri, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2022
- Primary completion
- 30 Jun 2023
- Completion
- 30 Jun 2023
- Last update posted
- 22 Dec 2023
- Registered enrollment
- 60
- Registry id
- NCT04862689
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.